PURPOSE: To assess, in a retrospective cohort study, rates and predictors of first and recurrent stroke in patients treated with cranial irradiation (CRT) and/or cervical irradiation at ≤18 years of age. METHODS AND MATERIALS: We performed chart abstraction (n=383) and phone interviews (n=104) to measure first and recurrent stroke in 383 patients who received CRT and/or cervical radiation at a single institution between 1980 and 2009. Stroke was defined as a physician diagnosis and symptoms consistent with stroke. Incidence of first stroke was number of first strokes per person-years of observation after radiation. We used survival analysis techniques to determine cumulative incidence of first and recurrent stroke. RESULTS: Among 325 subjects with sufficient follow-up data, we identified 19 first strokes (13 ischemic, 4 hemorrhagic, 2 unknown subtype) occurring at a median age of 24 years (interquartile range 17-33 years) in patients treated with CRT. Imaging was reviewed when available (n=13), and the stroke was confirmed in 12. Overall rate of first stroke was 625 (95% confidence interval [CI] 378-977) per 100,000 person-years. The cumulative incidence of first stroke was 2% (95% CI 0.01%-5.3%) at 5 years and 4% (95% CI 2.0%-8.4%) at 10 years after irradiation. With each 100-cGy increase in the radiation dose, the stroke hazard increased by 5% (hazard ratio 1.05; 95% CI 1.01-1.09; P=.02). We identified 6 recurrent strokes; 5 had available imaging that confirmed the stroke. Median time to recurrence was 15 months (interquartile range 6 months-3.2 years) after first stroke. The cumulative incidence of recurrent stroke was 38% (95% CI 17%-69%) at 5 years and 59% (95% CI 27%-92%) at 10 years after first stroke. CONCLUSION: Cranial irradiation puts childhood cancer survivors at high risk of both first and recurrent stroke. Stroke prevention strategies for these survivors are needed.
PURPOSE: To assess, in a retrospective cohort study, rates and predictors of first and recurrent stroke in patients treated with cranial irradiation (CRT) and/or cervical irradiation at ≤18 years of age. METHODS AND MATERIALS: We performed chart abstraction (n=383) and phone interviews (n=104) to measure first and recurrent stroke in 383 patients who received CRT and/or cervical radiation at a single institution between 1980 and 2009. Stroke was defined as a physician diagnosis and symptoms consistent with stroke. Incidence of first stroke was number of first strokes per person-years of observation after radiation. We used survival analysis techniques to determine cumulative incidence of first and recurrent stroke. RESULTS: Among 325 subjects with sufficient follow-up data, we identified 19 first strokes (13 ischemic, 4 hemorrhagic, 2 unknown subtype) occurring at a median age of 24 years (interquartile range 17-33 years) in patients treated with CRT. Imaging was reviewed when available (n=13), and the stroke was confirmed in 12. Overall rate of first stroke was 625 (95% confidence interval [CI] 378-977) per 100,000 person-years. The cumulative incidence of first stroke was 2% (95% CI 0.01%-5.3%) at 5 years and 4% (95% CI 2.0%-8.4%) at 10 years after irradiation. With each 100-cGy increase in the radiation dose, the stroke hazard increased by 5% (hazard ratio 1.05; 95% CI 1.01-1.09; P=.02). We identified 6 recurrent strokes; 5 had available imaging that confirmed the stroke. Median time to recurrence was 15 months (interquartile range 6 months-3.2 years) after first stroke. The cumulative incidence of recurrent stroke was 38% (95% CI 17%-69%) at 5 years and 59% (95% CI 27%-92%) at 10 years after first stroke. CONCLUSION: Cranial irradiation puts childhood cancer survivors at high risk of both first and recurrent stroke. Stroke prevention strategies for these survivors are needed.
Authors: N J Ullrich; R Robertson; D D Kinnamon; R M Scott; M W Kieran; C D Turner; S N Chi; L Goumnerova; M Proctor; N J Tarbell; K J Marcus; S L Pomeroy Journal: Neurology Date: 2007-03-20 Impact factor: 9.910
Authors: Lucille D A Dorresteijn; Arnoud C Kappelle; Natasja M J Scholz; Marten Munneke; José T Scholma; Alfons J M Balm; Harry Bartelink; Willem Boogerd Journal: Eur J Cancer Date: 2005-05 Impact factor: 9.162
Authors: M Fouladi; J Langston; R Mulhern; D Jones; X Xiong; J Yang; S Thompson; A Walter; R Heideman; L Kun; A Gajjar Journal: J Clin Oncol Date: 2000-02 Impact factor: 44.544
Authors: Cynthia J Campen; Sarah M Kranick; Scott E Kasner; Sudha K Kessler; Robert A Zimmerman; Robert Lustig; Peter C Phillips; Phillip B Storm; Sabrina E Smith; Rebecca Ichord; Michael J Fisher Journal: Stroke Date: 2012-09-11 Impact factor: 7.914
Authors: Daniel C Bowers; D Elizabeth McNeil; Yan Liu; Yutaka Yasui; Marilyn Stovall; James G Gurney; Melissa M Hudson; Sarah S Donaldson; Roger J Packer; Pauline A Mitby; Catherine E Kasper; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2005-09-20 Impact factor: 50.717
Authors: Robert J Hayashi; Stuart S Winter; Kimberly P Dunsmore; Meenakshi Devidas; Zhiguo Chen; Brent L Wood; Michelle L Hermiston; David T Teachey; Sherrie L Perkins; Rodney R Miles; Elizabeth A Raetz; Mignon L Loh; Naomi J Winick; William L Carroll; Stephen P Hunger; Megan S Lim; Thomas G Gross; Catherine M Bollard Journal: J Clin Oncol Date: 2020-06-17 Impact factor: 44.544
Authors: Heather J Fullerton; Kayla Stratton; Sabine Mueller; Wendy W Leisenring; Greg T Armstrong; Rita E Weathers; Marilyn Stovall; Charles A Sklar; Robert E Goldsby; Les L Robison; Kevin R Krull Journal: Neurology Date: 2015-08-26 Impact factor: 9.910
Authors: Kevin R Krull; Yutaka Yasui; Yadav Sapkota; Yin Ting Cheung; Wonjong Moon; Kyla Shelton; Carmen L Wilson; Zhaoming Wang; Daniel A Mulrooney; Jinghui Zhang; Gregory T Armstrong; Melissa M Hudson; Leslie L Robison Journal: Clin Cancer Res Date: 2019-08-28 Impact factor: 12.531
Authors: Sabine Mueller; Cassie N Kline; Robin A Buerki; Yan Chen; Yutaka Yasui; Rebecca Howell; Kevin C Oeffinger; Wendy M Leisenring; Leslie L Robison; Gregory T Armstrong; Heather J Fullerton; Kevin R Krull Journal: Cancer Date: 2019-12-06 Impact factor: 6.860
Authors: Allison A King; Kristy Seidel; Chongzhi Di; Wendy M Leisenring; Stephanie Mabry Perkins; Kevin R Krull; Charles A Sklar; Daniel M Green; Gregory T Armstrong; Lonnie K Zeltzer; Elizabeth Wells; Marilyn Stovall; Nicole J Ullrich; Kevin C Oeffinger; Leslie L Robison; Roger J Packer Journal: Neuro Oncol Date: 2017-05-01 Impact factor: 12.300